What Is Actually in Blue Lotus: 185 Compounds, and the Class Nobody Discusses
A 2025 study from Cairo University analysed Egyptian blue lotus grown in a Cairo botanical garden and identified 185 secondary metabolites across ten chemical classes. Six alkaloids were found. Five are spermidine alkaloids and one is trigonelline. None is an aporphine, the class the market has discussed for decades. The paper names the plant inconsistently and its Methods record a different genus, so the species attribution should be treated as unresolved.
Key takeaways
- 185 secondary metabolites identified across ten chemical classes, in flower, leaf and stem analysed separately.
- Six alkaloids in total. Five are spermidine alkaloids, concentrated mainly in the flowers.
- Spermidine alkaloids are a completely different chemical class from the aporphines this market usually names.
- The same study confirmed apomorphine and nuciferine virtually absent, agreeing with an independent 2023 analysis.
- Antioxidant and enzyme results came from laboratory assays on extracts, not from studies in people.
The study, what it gets right, and what it does not
Which study analysed Egyptian Blue Lotus? Younis, Mohsen and colleagues at the Pharmacognosy Department, Faculty of Pharmacy, Cairo University, published open access in Scientific Reports on 19 December 2025. Material was collected from the El-Orman Botanical Garden in Cairo against herbarium voucher 3-8-2021, and analysed by high-resolution UHPLC/PDA/ESI-QTOF-MS across flower, leaf and stem separately. The paper names the plant inconsistently and its Methods record a different genus, so the species attribution should be treated as unresolved. See the note below.
Most chemistry published on this plant has a provenance problem. Retail material of unverified species, or a different species entirely, or the wrong plant part, or all three.
This study is better than most, and it still has one. The details are worth listing in full, including the part that does not reflect well on it.
What is strong. The material was collected in Egypt, from the El-Orman Botanical Garden in Cairo, in August 2021, rather than bought from a retailer. A herbarium voucher exists, numbered 3-8-2021. A botanist is named, Prof. Dr. Mohamed Gebaly. Flower, leaf and stem were analysed separately rather than pooled, which matters because compounds are not evenly distributed through a plant. The instrument was high-resolution mass spectrometry coupled to liquid chromatography, which separates a complex mixture before measuring it. Almost no other study on this flower can claim any of that.
And now the part I have to report against my own interest. The paper names the plant three different ways. The title says Nymphaea nouchali. The running title and half the figure captions say Nymphaea caerulea. And the Methods section, the one place that actually records what was authenticated, says N. nucifera. That is Nelumbo, the sacred lotus, a different genus in a different family.
It gets more awkward. The same voucher number, the same garden, the same month, the same herbarium and the same authenticator appear word for word in the same team's 2023 paper, which is genuinely about Nelumbo nucifera. The two paragraphs are identical apart from a couple of words.
I obtained the full supplementary file and searched it. It contains no voucher photograph, no herbarium sheet, and zero occurrences of the words herbarium, voucher, authentication, or the voucher number itself.
There are two innocent readings. A stale copy-paste in the methods, with a genuinely different specimen in the vial. Or the same physical accession used twice. The published record cannot tell them apart, and I am not accusing anyone of anything. But I am not going to describe the species as confirmed when the only sentence that confirms anything names the wrong family. Only inspection of voucher 3-8-2021 at Cairo University settles it. I have written to the corresponding authors to ask.
So read the findings below as what they are. The strongest chemistry anyone has published on this plant, from a real Egyptian garden with a real voucher, carrying a species discrepancy on its face that nobody has resolved.
The full paper is available open access through PubMed Central and at Nature. Anyone can check every word of that against the source, including the part I would rather not have found.
The six alkaloids
Which alkaloids are in Egyptian Blue Lotus? Six were identified: trigonelline, and five spermidine alkaloids, being di-p-coumaroyl spermidine, feruloyl coumaroyl spermidine, tri-coumaroyl spermidine, feruloyl dicoumaroyl spermidine, and di-feruloyl coumaroyl spermidine. They were concentrated mainly in the flowers.
Six alkaloids in the whole plant. Here they are:
Trigonelline. A simple alkaloid, widespread in the plant kingdom, familiar from coffee and fenugreek.
And five of a single class:
Di-p-coumaroyl spermidine. Feruloyl coumaroyl spermidine. Tri-coumaroyl spermidine. Feruloyl dicoumaroyl spermidine. Di-feruloyl coumaroyl spermidine.
Read that list against what this market talks about and the gap is the entire point of this article. Not apomorphine. Not nuciferine. Not nornuciferine. Not any aporphine at all.
Five of the six belong to a class that, as far as I can find, no vendor of this flower has ever mentioned.
What a spermidine alkaloid is
What are spermidine alkaloids? Compounds formed when spermidine, a small polyamine found in all living cells, bonds with hydroxycinnamic acids such as coumaric acid or ferulic acid. They are also called hydroxycinnamic acid amides, and are common in pollen and floral tissue across many plant families.
Two familiar things joined together.
Spermidine is a polyamine, a small molecule present in essentially every living cell and involved in cell growth. Coumaric and ferulic acids are hydroxycinnamic acids, the same family of plant phenolics found throughout the plant world.
Bond them and you get a hydroxycinnamic acid amide. The names above simply describe how many of each unit are attached: tri-coumaroyl spermidine carries three coumaroyl groups, feruloyl coumaroyl spermidine carries one of each.
These compounds are well known to plant scientists and turn up frequently in pollen and reproductive tissue across many families. That the Cairo team found them concentrated in the flowers rather than the leaf or stem fits that pattern.
What they are not is aporphine alkaloids. Structurally, biosynthetically and functionally they belong to a different part of plant chemistry entirely. This is not a variation on the story the market has been telling. It is a different story.
A reasonable inference. That these compounds have been overlooked because researchers arrived looking for aporphines is a plausible reading of the literature rather than a documented account. Earlier work targeted apomorphine and nuciferine specifically, and a targeted assay finds what it is calibrated to find. Whether anyone would have noticed the spermidines sooner using untargeted methods is not something the record answers.
The other 179 compounds
The alkaloids are a small fraction of what was identified. The 185 metabolites spread across ten chemical classes.
Phenolic acids. Ellagitannins. Flavonoids. Anthocyanins, which are the pigments responsible for blue and purple colour in plants and therefore relevant to a flower named for being blue. Alkaloids, the six above. Amino acids and vitamins. Organic acids. Fatty acids and amides. Lipids. Sugars.
This is a chemically rich plant. That was never the question. The question was always whether it is rich in the specific compounds it has been sold on, and the answer to that is no.
The same paper states it plainly. Verbatim: "In agreement with [8], both apomorphine and nuciferine were virtually absent in the blue lotus extract." Reference 8 is the 2023 analysis by Dosoky and colleagues.
Two teams, on different continents, using different instruments, in different years, reaching the same finding independently. I have set out that side of the evidence in the article on where the apomorphine claim came from.
What the assays measured, and what they did not
Did the study show health effects? No. It ran laboratory assays on extracts: DPPH, ABTS, nitric oxide and hydrogen peroxide scavenging, and acetylcholinesterase inhibition. These are tests performed in glassware to characterise an extract. They are not studies in people and do not establish that consuming the plant produces any effect.
This is the part where articles like this usually overreach, so I want to be exact.
The team ran antioxidant assays and an acetylcholinesterase inhibition assay, and reported measurable activity. Those are real results and they were properly conducted.
They are also tests done to an extract in a dish.
An antioxidant assay measures whether a substance neutralises a specific reactive compound under controlled laboratory conditions. It does not establish what happens when a person drinks a preparation, at what amount, whether the compounds survive digestion, whether they reach any tissue, or whether anything measurable follows. Those are separate questions and this study did not ask them.
No human trial of a Blue Lotus preparation has been published. Identifying a compound is not demonstrating an effect.
I make and sell preparations of this flower, which is exactly why that paragraph belongs here rather than in a footnote.
A note on the species name
One point of confusion worth clearing, because it causes people to dismiss this study wrongly.
The paper is titled for Nymphaea nouchali. Some readers see that and conclude it is about a different plant, the Indian water lily, rather than the Egyptian one.
It is not. The full designation is Nymphaea nouchali var. caerulea, and that is the current accepted botanical name for the plant formerly called Nymphaea caerulea. Same flower, updated classification: caerulea is now treated as a variety within the species nouchali. You can check this yourself: the international reference databases hold it under the identifier txid1616377, at the rank of variety, with the plain-English name "blue Egyptian lotus" and Nymphaea caerulea listed as a synonym.
Which makes one thing worth saying plainly. There are 231 DNA sequences on public record for that exact taxon. Anyone analysing this plant could match their material against them for nothing. As far as I can find, no chemistry paper on blue lotus ever has. The reference library has been open the whole time and nobody has walked in.
So a paper titled N. nouchali may well be about the Egyptian blue lotus. Check the variety before dismissing it. I have written more on the species tangle in the comparison of the plants sold under this name.
What this changes
For anyone buying this flower, the practical consequence is simple. A vendor describing apomorphine or nuciferine content is describing something no analysis has found in any plant material anyone has properly authenticated. That is now a checkable claim rather than a matter of opinion.
I have to be precise about the word independent, because I used it too loosely in the first version of this page. The 2025 Cairo study and the 2023 analysis are not two separate confirmations. The Cairo paper says in terms that it is in agreement with the earlier one, uses the same unusual phrase to describe the result, and was an untargeted survey rather than a test calibrated to hunt apomorphine specifically. The 2023 analysis, for its part, worked on a hexane perfumery extract, and its own authors wrote that those extraction conditions were not optimal for recovering these compounds. Two studies pointing the same way is worth something. It is not the same as two studies arriving there separately.
For the plant itself, the picture is more interesting than the one it replaces. A flower with 185 identified metabolites, a distinctive alkaloid profile concentrated in its blooms, and a class of compounds nobody in this market has discussed, is a more genuinely unusual plant than one propped up by a misattributed morphine derivative.
And one gap remains, which I will not close by implication. Every study named here analysed raw plant material: fresh flowers, dried petals, retail extract. None analysed a traditional preparation. Fermentation and prolonged extraction alter plant chemistry, so the profile of a flower is not automatically the profile of something made from it over weeks. Nobody has measured that, and that includes me.
For the wider picture of the plant, its history and how it is prepared, read the complete guide to Blue Lotus, Nymphaea caerulea. For how a spagyric preparation differs from a simple extract, see tincture compared with spagyric elixir, or the elixirs themselves.
Frequently asked questions
What compounds are in Blue Lotus?
A 2025 Cairo University analysis of Egyptian garden-grown material identified 185 secondary metabolites across ten chemical classes, including phenolic acids, ellagitannins, flavonoids, anthocyanins, alkaloids, amino acids, organic acids, fatty acids and amides, lipids and sugars.
Which alkaloids are in Egyptian Blue Lotus?
Six were identified: trigonelline, and five spermidine alkaloids, which are hydroxycinnamic acid amides of a polyamine. They were concentrated mainly in the flowers. None of the six is an aporphine alkaloid.
What are spermidine alkaloids?
A class formed when a polyamine called spermidine bonds with hydroxycinnamic acids such as coumaric and ferulic acid. They are common in pollen and reproductive tissue across many plant families, and are chemically unrelated to the aporphine alkaloids usually discussed in connection with Blue Lotus.
Which study is this and how reliable is it?
Younis, Mohsen and colleagues, published open access in Scientific Reports on 19 December 2025. Material came from the El-Orman Botanical Garden in Cairo against herbarium voucher 3-8-2021, and was analysed by high-resolution UHPLC/PDA/ESI-QTOF-MS across flower, leaf and stem separately. One caveat is important: the paper names the plant three different ways, and its Methods section records a different genus entirely, so the species attribution is unresolved on the published record.
Does this mean Blue Lotus has proven effects?
No. The antioxidant and enzyme-inhibition results were laboratory assays on extracts in glassware, not studies in people. Identifying a compound is not the same as demonstrating an effect at a realistic amount, and no human trial of a Blue Lotus preparation has been published.
This article summarises published research for educational interest. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any condition. Our products are botanical goods for adults 18 and over.
Keep Reading
Related Articles
Nuciferine and Blue Lotus: What the Research Actually Shows
The compound, the wrong plant, and what the studies report.
The Botany and Chemistry of Blue Lotus
What the plant is, and what it is made of.
